October 8th 2024
Light delves into the science behind the new peer-reviewed data assessing benzene presence and formation in benzoyl peroxide products.
October 7th 2024
New peer-reviewed research published in the Journal of Investigative Dermatology examined 111 products at room temperature.
September 27th 2024
Key highlights of the presentations included data on delgocitinib for atopic hand eczema, and tralokinumab for head and neck atopic dermatitis.
September 26th 2024
Through collaboration with Nimbus Therapeutics and Schrodinger, zasocitinib’s AI-driven design maximizes its fit within the targeted enzyme.
September 24th 2024
The FDA has set a PDUFA target action date of May 22, 2025.